Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roviello, F.
Right arrow Articles by Pinto, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roviello, F.
Right arrow Articles by Pinto, E.

Annals of Surgical Oncology, Vol 6, Issue 8 739-745, Copyright © 1999 by Society of Surgical Oncology

ARTICLES

P53 accumulation is a prognostic factor in intestinal-type gastric carcinoma but not in the diffuse type

F. Roviello, D. Marrelli, C. Vindigni, A. De Stefano, D. Spina and E. Pinto
Istituto di Scienze Chirurgiche, University of Siena, Italy. roviello@unisi.it

BACKGROUND: The prognostic value of p53 nuclear accumulation in gastric cancer is still unclear, as shown by the discordant results still reported in the literature. In this study, we evaluated the correlation between p53 accumulation and long-term survival of patients resected for intestinal and diffuse-type gastric cancer. METHODS: Eighty-three patients with carcinoma of the intestinal type and 53 patients with carcinoma of the diffuse type were included in the study. Immunohistochemical staining of the paraffin sections was performed by using monoclonal antibody DO1; cases were considered positive when nuclear immunostaining was observed in 10% or more of the tumor cells. Prognostic significance of different variables was investigated by univariate and multivariate analysis. RESULTS: p53 positivity was found in 51.8% of intestinal-type and 50.9% of diffuse-type cases. No significant correlation between the rate of p53 overexpression and age, sex, tumor location, tumor size, depth of invasion, lymph node involvement, distant metastases, and surgical radicality was found in the two groups of patients. A statistically significant difference in survival rate was observed between p53-negative and p53-positive cases in the intestinal type (P < .05), confirmed by multivariate analysis (P < .005; relative risk = 3.09). On the contrary, no correlation with survival was found in diffuse-type cases according to p53 overexpression. CONCLUSIONS: These results suggest that the immunohistochemical detection of p53 accumulation is a useful indicator of poor prognosis in the intestinal but not in the diffuse type of gastric cancer, and are indicative of distinct molecular pathways and pattern of progression in the two histotypes.


This article has been cited by other articles:


Home page
 Ann. Surg. Oncol.Home page
Y.-Y. Chou, Y.-M. Jeng, T.-T. Lee, F.-C. Hu, H.-L. Kao, W.-C. Lin, P.-L. Lai, R.-H. Hu, and R.-H. Yuan
Cytoplasmic CD24 Expression Is a Novel Prognostic Factor in Diffuse-Type Gastric Adenocarcinoma
Ann. Surg. Oncol., October 1, 2007; 14(10): 2748 - 2758.
[Abstract] [Full Text] [PDF]

Home page
 INT J SURG PATHOLHome page
J. Pinto-de-Sousa, L. David, R. Almeida, D. Leitao, J. R. Preto, M. Seixas, and A. Pimenta
c-erb B-2 Expression Is Associated with Tumor Location and Venous Invasion and Influences Survival of Patients with Gastric Carcinoma
International Journal of Surgical Pathology, October 1, 2002; 10(4): 247 - 256.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Society of Surgical Oncology.